Skip to content
TrialScanner

NCT01712412

Phase 2a Study of IW-9179 to Treat Functional Dyspepsia

Phase 2TerminatedIRWDLead

Registry record

Lead sponsor
Ironwood Pharmaceuticals, Inc.
Conditions
Dyspepsia; Functional Gastrointestinal Disorders
Primary completion
Feb 2014Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT01712412 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT01712412: Phase 2a Study of IW-9179 to... | TrialScanner